Supartz (Sodium Hyaluronate) for the Treatment of Knee Osteoarthritis: A Review of Efficacy and Safety

As concerns about the safety of systemic oral pharmacologic treatments for knee osteoarthritis (OA) mount, clinicians have increased the use of intra-articular hyaluronic acid (IA-HA) in managing mild-to-moderate knee OA. Supartz (sodium hyaluronate; Seikagaku Corporation, Tokyo, Japan) is the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronstone, Amy, Neary, Jacob T, Lambert, Todd H, Dasa, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463231/
https://www.ncbi.nlm.nih.gov/pubmed/31019370
http://dx.doi.org/10.1177/1179544119835221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463231/
https://www.ncbi.nlm.nih.gov/pubmed/31019370
http://dx.doi.org/10.1177/1179544119835221

Ejemplares similares